CO60 Predicting Treatment Effects from Surrogate Endpoints in First-Line (1L) Metastatic Castration-Resistant Prostate Cancer (MCRPC)
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.132
https://www.valueinhealthjournal.com/article/S1098-3015(23)03262-X/fulltext
Title :
CO60 Predicting Treatment Effects from Surrogate Endpoints in First-Line (1L) Metastatic Castration-Resistant Prostate Cancer (MCRPC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03262-X&doi=10.1016/j.jval.2023.09.132
First page :
Section Title :
Open access? :
No
Section Order :
10768